SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

1 hedge funds and large institutions have $1.09M invested in Sonnet BioTherapeutics in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
1
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$253K
2
-$218K
3
-$124K
4
BIT
BlackRock Institutional Trust
California
-$101K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$92K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$314K
2
$205K
3
$176K
4
$100K
5
$82K
6
$62.4K
7
$49K
8
$36K
9
$24K
10
$18K
11
$14K
12
$4K
13
$3K
14
$1K
15
$74
16
–
17
–
18
–
19
–
20
–
21
–